The DOI matches its Crossref record; 52 of the 53 references it cites were found in a registry or an index.
The genomic sequence of the Chinese hamster ovary (CHO)-K1 cell line
Open accessAbstract
Since 1987, immortalized cells from the ovary of a Chinese hamster have been the workhorse for producing recombinant therapeutics, including monoclonal antibodies, blood factors, hormones, growth factors and enzymes. Xu et al. provide the genome sequence of the ancestral CHO-K1 cell line, which should aid in the optimization of current production cell lines. Chinese hamster ovary (CHO)–derived cell lines are the preferred host cells for the production of therapeutic proteins. Here we present a draft genomic sequence of the CHO-K1 ancestral cell line. The assembly comprises 2.45 Gb of genomic sequence, with 24,383 predicted genes. We associate most of the assembled scaffolds with 21 chromosomes isolated by microfluidics to identify chromosomal locations of genes. Furthermore, we investigate genes involved in glycosylation, which affect therapeutic protein quality, and viral susceptibility genes, which are relevant to cell engineering and regulatory concerns. Homologs of most human glycosylation-associated genes are present in the CHO-K1 genome, although 141 of these homologs are not expressed under exponential growth conditions. Many important viral entry genes are also present in the genome but not expressed, which may explain the unusual viral resistance property of CHO cell lines. We discuss how the availability of this genome sequence may facilitate genome-scale science for the optimization of biopharmaceutical protein production.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The availability of genomic sequences has enabled CHO cell engineering with unprecedented precision using engineered nucleases, including zinc finger nucleases (ZFNs) and transcription activator like nucleases (TALENs) and the clustered regularly interspaced short palindromic repeats (CRISPR) system [71–73,75,76].”
From Glycoengineering Chinese hamster ovary cells: a short history (2021) · cites this paper as [71]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“CHO cells do not express alpha-1,3-galactosyltransferases, which produce the immunogenic alpha-galactosyl epitope (although they have the gene), and the expression of CMP-N-acetylneuraminic acid hydroxylase, which produces CMP-NeuGc, is virtually absent [27,71,72].”
From Glycoengineering Chinese hamster ovary cells: a short history (2021) · cites this paper as [71]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Advances in various omics technologies have significantly improved our understanding of CHO cells at different levels and enabled the rational targeting of glycosylation effectors for improved biopharmaceutical production [27,71,72,150–152].”
From Glycoengineering Chinese hamster ovary cells: a short history (2021) · cites this paper as [71]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Initial sequencing and comparative analysis of the mouse genome
Mouse Genome Sequencing Consortium (2002) · Nature · doi:10.1038/nature01262 · Cited by 7,187
De novo assembly of human genomes with massively parallel short read sequencing
Li, R., Zhu, H., Ruan, J., Qian, W., Fang, X., Shi, Z., Li, Y., Li, S., Shan, G., Kristiansen, K., et al. (2010) · Genome Research · doi:10.1101/gr.097261.109 · Cited by 2,926
Self-citationGenome sequence of the Brown Norway rat yields insights into mammalian evolution
Gibbs, R. A., Weinstock, G. M., Metzker, M. L., Muzny, D. M., Sodergren, E. J., Scherer, S. E., Scott, G., Steffen, D. L., Worley, K. C., Burch, P. E., et al. (2004) · Nature · doi:10.1038/nature02426 · Cited by 2,170
Production of recombinant protein therapeutics in cultivated mammalian cells
Wurm, F. M. (2004) · Nature Biotechnology · doi:10.1038/nbt1026 · Cited by 2,032 · cited 9×
“This is consistent with the observation that CHO cells do not normally show ST6Gal activity19, whereas terminal α(2,3)-linked sialic acid residues are abundant.”
InfluentialAssembly algorithms for next-generation sequencing data
Miller, J. R., Koren, S., & Sutton, G. G. (2010) · Genomics · doi:10.1016/j.ygeno.2010.03.001 · Cited by 1,186
Metabolic engineering of Escherichia coli for direct production of 1,4-butanediol
Yim, H. H., Haselbeck, R. J., Niu, W., Pujol-Baxley, C., Burgard, A. P., Boldt, J., Khandurina, J., Trawick, J. D., Osterhout, R. E., Stephen, R., et al. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.580 · Cited by 1,114
The role of sialic acid in determining the survival of glycoproteins in the circulation
Morell, A. G., Gregoriadis, G., Scheinberg, I. H., Hickman, J., & Ashwell, G. (1971) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)76994-4 · Cited by 1,072
A Novel Role for 3-O-Sulfated Heparan Sulfate in Herpes Simplex Virus 1 Entry
Shukla, D., Liu, J., Blaiklock, P., Shworak, N. W., Bai, X., Esko, J. D., Cohen, G. H., Eisenberg, R. J., ROSENBERG, R. D., & Spear, P. G. (1999) · Cell · doi:10.1016/s0092-8674(00)80058-6 · Cited by 1,053
Post-translational modifications in the context of therapeutic proteins
Walsh, G., & Jefferis, R. (2006) · Nature Biotechnology · doi:10.1038/nbt1252 · Cited by 1,007 · cited 1×
“For some of these proteins, differential glycosylation can substantially affect functional activity and/or in vivo circulatory half-lif”
Annotation, submission and screening of repetitive elements in Repbase: RepbaseSubmitter and Censor
Kohany, O., Gentles, A. J., Hankus, L., & Jurka, J. (2006) · BMC Bioinformatics · doi:10.1186/1471-2105-7-474 · Cited by 897
Flagged first, then by citations
1 of the 53 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–200 of 786
Hayakawa, T., Suzuki–Hashido, N., Matsui, A., & Go, Y. (2014) · Molecular Biology and Evolution · doi:10.1093/molbev/msu144 · Cited by 77
Integrin mediates cell entry of the SARS-CoV-2 virus independent of cellular receptor ACE2
Liu, J., Lü, F., Chen, Y., Plow, E. F., & Qin, J. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.101710 · Cited by 76
“CHO-K1 is a well-established cell line containing RGD-binding integrins, notably α5β1 (33, 34).”
Synthetic promoters for CHO cell engineering
Brown, A. J., Sweeney, B., Mainwaring, D. O., & James, D. C. (2014) · Biotechnology and Bioengineering · doi:10.1002/bit.25227 · Cited by 78
Development of recombinant Chinese hamster ovary cell lines for therapeutic protein production
Noh, S. M., Sathyamurthy, M., & Lee, G. M. (2013) · Current Opinion in Chemical Engineering · doi:10.1016/j.coche.2013.08.002 · Cited by 76
Radiosensitization Effect of Gold Nanoparticles in Proton Therapy
Cunningham, C., de Kock, M., Engelbrecht, M., Miles, X., Slabbert, J. P., & Vandevoorde, C. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.699822 · Cited by 75
Goey, C. H., Alhuthali, S., & Kontoravdi, C. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.03.021 · Cited by 72
Hansen, H. G., Pristovšek, N., Kildegaard, H. F., & Lee, G. M. (2016) · Biotechnology Advances · doi:10.1016/j.biotechadv.2016.11.008 · Cited by 73
Mukhopadhyay, I., Kulkarni, A., Aranake, S., Karnik, P., Shetty, M., Thorat, S., Ghosh, I., Wale, D. P., Bhosale, V. M., & Khairatkar-Joshi, N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097005 · Cited by 71
Glycoengineering in CHO cells: advances in systems biology
Tejwani, V., Andersen, M. R., Nam, J. H., & Sharfstein, S. T. (2018) · Biotechnology Journal · doi:10.1002/biot.201700234 · Cited by 70
Self-citationValente, K. N., Levy, N. E., Lee, K. H., & Lenhoff, A. M. (2018) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2018.01.004 · Cited by 70
Self-citationDissecting structure-function of 3-O-sulfated heparin and engineered heparan sulfates
Karlsson, R. T. G., Chopra, P., Joshi, A., Yang, Z., Vakhrushev, S. Y., Clausen, T. M., Painter, C. D., Szekeres, G. P., Chen, Y., Sandoval, D. R., et al. (2021) · Science Advances · doi:10.1126/sciadv.abl6026 · Cited by 66
Blondel, C. J., Park, J. S., Hubbard, T. P., Pacheco, A. R., Kuehl, C. J., Walsh, M. J., Davis, B. M., Gewurz, B. E., Doench, J. G., & Waldor, M. K. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.06.010 · Cited by 67
“CHO cells only express one FUT, FUT8, which generates the a-1,6 core linkage in N-glycans (Xu et al., 2011), leaving them devoid of terminally fucosylated glycans (Figure 5H).”
Fischer, S., Buck, T., Wagner, A., Ehrhart, C., Giancaterino, J., Mang, S., Schad, M., Mathias, S., Aschrafi, A., Handrick, R., et al. (2014) · Biotechnology Journal · doi:10.1002/biot.201400306 · Cited by 70
Chan, K. F., Shahreel, W., Wan, C., Teo, G., Hayati, N., Tay, S. J., Tong, W. H., Yang, Y., Rudd, P. M., Zhang, P., et al. (2015) · Biotechnology Journal · doi:10.1002/biot.201500331 · Cited by 70
Veith, N., Ziehr, H., MacLeod, R. A. F., & Reamon-Buettner, S. M. (2016) · BMC Biotechnology · doi:10.1186/s12896-016-0238-0 · Cited by 69
Miller, J. R., Koren, S., Dilley, K. A., Puri, V., Brown, D., Harkins, D. M., Thibaud‐Nissen, F., Rosen, B. D., Chen, X., Tu, Z. J., et al. (2018) · GigaScience · doi:10.1093/gigascience/gix135 · Cited by 68
“C6/36 joins CHO [83,84,85] and HeLa [55] as another cell line to have its genome de novo assembled.”
Engineering Mammalian Mucin-type O-Glycosylation in Plants
Yang, Z., Drew, D. P., Jørgensen, B., Mandel, U., Bach, S. S., Ulvskov, P., Levery, S. B., Bennett, E., Clausen, H., & Petersen, B. L. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.312918 · Cited by 67
The use of ‘Omics technology to rationally improve industrial mammalian cell line performance
Lewis, A. M., Abu‐Absi, N. R., Borys, M., & Li, Z. J. (2015) · Biotechnology and Bioengineering · doi:10.1002/bit.25673 · Cited by 67
Cao, Y., Kimura, S., Itoi, T., Honda, K., Ohtake, H., & Ōmasa, T. (2011) · Biotechnology and Bioengineering · doi:10.1002/bit.24347 · Cited by 69
Edwards, E., Livanos, M., Krueger, A., Dell, A., Haslam, S. M., Smales, C. M., & Bracewell, D. G. (2022) · Biotechnology and Bioengineering · doi:10.1002/bit.28066 · Cited by 74
Fan, Y., del Val, I. J., Müller, C. R., Lund, A. M., Sen, J. W., Rasmussen, S. K., Kontoravdi, C., Baycin‐Hizal, D., Betenbaugh, M. J., Weilguny, D., et al. (2015) · Biotechnology and Bioengineering · doi:10.1002/bit.25620 · Cited by 69
Self-citationImproving Immunotherapy Through Glycodesign
Buettner, M. J., Shah, S. R., Saeui, C. T., Ariss, R., & Yarema, K. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02485 · Cited by 68
Gao, S., Bertrand, D., Chia, B. K. H., & Nagarajan, N. (2016) · Genome biology · doi:10.1186/s13059-016-0951-y · Cited by 65
New Insights into Cell Culture Technology
Gowder, S. J. (2017) · InTech eBooks · doi:10.5772/62590 · Cited by 67
Mitigating Clonal Variation in Recombinant Mammalian Cell Lines
Lee, J. S., Kildegaard, H. F., Lewis, N. E., & Lee, G. M. (2019) · Trends in biotechnology · doi:10.1016/j.tibtech.2019.02.007 · Cited by 65
Self-citationRupp, O., Becker, J. S., Brinkrolf, K., Timmermann, C., Borth, N., Pühler, A., Noll, T., & Goesmann, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085568 · Cited by 64
Nicolae, A., Wahrheit, J., Bahnemann, J., Zeng, A., & Heinzle, E. (2014) · BMC Systems Biology · doi:10.1186/1752-0509-8-50 · Cited by 64
Mital, S., Christie, G., & Dikicioǧlu, D. (2021) · Microbial Cell Factories · doi:10.1186/s12934-021-01698-w · Cited by 68
Bailey‐Kellogg, C., Gutiérrez, A. H., Moise, L., Terry, F. E., Martin, W. D., & Groot, A. S. D. (2014) · Biotechnology and Bioengineering · doi:10.1002/bit.25286 · Cited by 65
Bedoya-López, A., Estrada, K., Sánchez‐Flores, A., Ramı́rez, O. T., Altamirano, C., Segovia, L., Miranda‐Ríos, J., Trujillo‐Roldán, M. A., & Valdez‐Cruz, N. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151529 · Cited by 65
Farrell, A., McLoughlin, N., Milne, J. J., Marison, I. W., & Bones, J. (2014) · Journal of Proteome Research · doi:10.1021/pr500219b · Cited by 64
Madsen, J. A., Farutin, V., Carbeau, T., Wudyka, S., Yin, Y., Smith, S., Anderson, J., & Capila, I. (2015) · mAbs · doi:10.1080/19420862.2015.1082017 · Cited by 59
Transcriptome analysis of epithelioma papulosum cyprini cells after SVCV infection
Yuan, J., Yang, Y., Nie, H., Li, L., Gu, W.-G., Lin, L., Zou, M., Liu, X., Wang, M., & Gu, Z. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-935 · Cited by 57
Self-citationPrecision genome editing: A small revolution for glycobiology
Steentoft, C., Bennett, E., Schjoldager, K. T.-B. G., Vakhrushev, S. Y., Wandall, H. H., & Clausen, H. (2014) · Glycobiology · doi:10.1093/glycob/cwu046 · Cited by 62
Sealover, N. R., Davis, A., Brooks, J. K., George, H. J., Kayser, K. J., & Lin, N. (2013) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2013.06.006 · Cited by 58
Marx, N., Grünwald‐Gruber, C., Bydlinski, N., Dhiman, H., Ly, N. N., Klanert, G., & Borth, N. (2018) · Biotechnology Journal · doi:10.1002/biot.201700217 · Cited by 57
A system for site-specific integration of transgenes in mammalian cells
Chi, X., Zheng, Q., Jiang, R., Chen-Tsai, R. Y., & Kong, L.-J. (2019) · PLoS ONE · doi:10.1371/journal.pone.0219842 · Cited by 59
The impact of anti-apoptotic gene Bcl-2∆ expression on CHO central metabolism
Templeton, N., Lewis, A., Dorai, H., Qian, E. A., Campbell, M., Smith, K. D., Lang, S. E., Betenbaugh, M. J., & Young, J. D. (2014) · Metabolic Engineering · doi:10.1016/j.ymben.2014.06.010 · Cited by 57
Self-citationRibosome profiling-guided depletion of an mRNA increases cell growth rate and protein secretion
Kallehauge, T. B., Li, S., Pedersen, L. E., Ha, T. K., Ley, D., Andersen, M. R., Kildegaard, H. F., Lee, G. M., & Lewis, N. E. (2017) · Scientific Reports · doi:10.1038/srep40388 · Cited by 57
“We can now begin to understand the molecular basis of protein expression thanks to recent efforts to sequence the genomes of cell lines utilized for recombinant expression 1–3 .”
Self-citationEffects of copper on CHO cells: Insights from gene expression analyses
Yuk, I. H. Y., Zhang, J. D., Ebeling, M., Berrera, M., Gomez, N. V., Werz, S., Meiringer, C. T. A., Shao, Z., Swanberg, J. C., Lee, K. H., et al. (2014) · Biotechnology Progress · doi:10.1002/btpr.1868 · Cited by 57
Self-citationMammalian Cell Line Developments in Speed and Efficiency
Estes, S. D., & Melville, M. W. (2013) · Advances in biochemical engineering, biotechnology · doi:10.1007/10_2013_260 · Cited by 65
Lakshmanan, M., Kok, Y. J., Lee, A., Kyriakopoulos, S., Lim, H. L., Teo, G., Poh, S. L., Tang, W. Q., Hong, J. K., Tan, A. H., et al. (2019) · Biotechnology and Bioengineering · doi:10.1002/bit.27014 · Cited by 57
Perfusion culture of Chinese Hamster Ovary cells for bioprocessing applications
MacDonald, M. A., Nöbel, M., Roche Recinos, D., Martínez, V. S., Schulz, B. L., Howard, C. B., Baker, K., Shave, E., Lee, Y. Y., Marcellin, E., et al. (2022) · Critical Reviews in Biotechnology · doi:10.1080/07388551.2021.1998821 · Cited by 55
Genomics in mammalian cell culture bioprocessing
Wuest, D., Harcum, S. W., & Lee, K. H. (2011) · Biotechnology Advances · doi:10.1016/j.biotechadv.2011.10.010 · Cited by 55
Self-citationUtilization and evaluation of CHO‐specific sequence databases for mass spectrometry based proteomics
Meleady, P., Hoffrogge, R., Henry, M. A., Rupp, O., Bort, J. A. H., Clarke, C., Brinkrolf, K., Kelly, S., Muller, B. Z., Doolan, P., et al. (2012) · Biotechnology and Bioengineering · doi:10.1002/bit.24476 · Cited by 62
Amann, T., Hansen, A. H., Kol, S., Hansen, H. G., Arnsdorf, J., Nallapareddy, S., Voldborg, B. G. R., Lee, G. M., Andersen, M. R., & Kildegaard, H. F. (2018) · Metabolic Engineering · doi:10.1016/j.ymben.2018.11.014 · Cited by 55
Self-citationJadhav, V., Hackl, M., Hernandez Bort, J. A., Wieser, M., Harreither, E., Kunert, R., Borth, N., & Grillari, J. (2012) · Biotechnology and Bioengineering · doi:10.1002/bit.24490 · Cited by 55
miRNAs – pathway engineering of CHO cell factories that avoids translational burdening
Hackl, M., Borth, N., & Grillari, J. (2012) · Trends in biotechnology · doi:10.1016/j.tibtech.2012.05.002 · Cited by 54
Sanchez, N., Kelly, P. S., Gallagher, C., Lao, N. T., Clarke, C., CLYNES, M. M., & Barron, N. (2013) · Biotechnology Journal · doi:10.1002/biot.201300325 · Cited by 54
High‐throughput screening and selection of mammalian cells for enhanced protein production
Priola, J. J., Calzadilla, N., Baumann, M., Borth, N., Tate, C. G., & Betenbaugh, M. J. (2016) · Biotechnology Journal · doi:10.1002/biot.201500579 · Cited by 56
Self-citationHang, Q., Isaji, T., Hou, S., Wang, Y., Fukuda, T., & Gu, J. (2017) · Molecular and Cellular Biology · doi:10.1128/mcb.00558-16 · Cited by 53
Towards next generation CHO cell line development and engineering by systems approaches
Hong, J. K., Lakshmanan, M., Goudar, C. T., & Lee, D. (2018) · Current Opinion in Chemical Engineering · doi:10.1016/j.coche.2018.08.002 · Cited by 53
Graham, R. J., Bhatia, H., & Yoon, S. (2019) · Biotechnology and Bioengineering · doi:10.1002/bit.27140 · Cited by 52
Sieck, J. B., Budach, W. E., Suemeghy, Z., Leist, C., Villiger, T. K., Morbidelli, M., & Šoóš, M. (2014) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2014.08.042 · Cited by 51
Recovery of Chinese hamster ovary host cell proteins for proteomic analysis
Valente, K. N., Schaefer, A. K., Kempton, H. R., Lenhoff, A. M., & Lee, K. H. (2013) · Biotechnology Journal · doi:10.1002/biot.201300190 · Cited by 51
Self-citationIdentifying the CHO Secretome using Mucin-type O-Linked Glycosylation and Click-chemistry
Slade, P. G., Hajivandi, M., Bartel, C. M., & Gorfien, S. F. (2012) · Journal of Proteome Research · doi:10.1021/pr300810f · Cited by 51
Hirata, T., Mishra, S. K., Nakamura, S., Saito, K., Motooka, D., Takada, Y. K., Kanzawa, N., Murakami, Y., Maeda, Y., Fujita, M., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02799-0 · Cited by 51
Attenuating apoptosis in Chinese hamster ovary cells for improved biopharmaceutical production
Henry, M. N., MacDonald, M. A., Orellana, C. A., Gray, P. P., Gillard, M., Baker, K. N., Nielsen, L. K., Marcellin, E., Mahler, S. M., & Martínez, V. S. (2020) · Biotechnology and Bioengineering · doi:10.1002/bit.27269 · Cited by 51
“The CHO genome is inherently unstable (Pilbrough, Munro, & Gray, 2009; Xu et al., 2011), and traditional random plasmid integration does not control the genomic location of insertion.”
CRISPR‐Cas targeted plasmid integration into mammalian cells via non‐homologous end joining
Bachu, R., Bergareche, I., & Chasin, L. A. (2015) · Biotechnology and Bioengineering · doi:10.1002/bit.25629 · Cited by 50
Glyco-engineering for biopharmaceutical production in moss bioreactors
Decker, E. L., Parsons, J., & Reski, R. (2014) · Frontiers in Plant Science · doi:10.3389/fpls.2014.00346 · Cited by 51
Mammalian cells as biopharmaceutical production hosts in the age of omics
Dietmair, S., Nielsen, L. K., & Timmins, N. E. (2011) · Biotechnology Journal · doi:10.1002/biot.201100369 · Cited by 52
Genomic DNA Extraction from Cells by Electroporation on an Integrated Microfluidic Platform
Geng, T., Bao, N., Sriranganathanw, N., Li, L., & Lu, C. (2012) · Analytical Chemistry · doi:10.1021/ac3026064 · Cited by 50
Lim, U.-M., Yap, M. G. S., Lim, Y. P., Goh, L., & Ng, S. K. (2013) · Journal of Proteome Research · doi:10.1021/pr400352n · Cited by 49
Lu, J., Isaji, T., Im, S., Fukuda, T., Kameyama, A., & Gu, J. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.712836 · Cited by 50
Zhong, X., & Wright, J. F. (2013) · International Journal of Cell Biology · doi:10.1155/2013/273086 · Cited by 49
Promoter and Terminator Discovery and Engineering
Deaner, M., & Alper, H. S. (2016) · Advances in biochemical engineering, biotechnology · doi:10.1007/10_2016_8 · Cited by 48
Chung, C., Wang, Q., Yang, S., Yin, B., Zhang, H., & Betenbaugh, M. J. (2016) · Biotechnology Journal · doi:10.1002/biot.201600502 · Cited by 50
Self-citationHilliard, W., MacDonald, M. L., & Lee, K. H. (2020) · Biotechnology and Bioengineering · doi:10.1002/bit.27432 · Cited by 48
“Historically, genetic studies in CHO have been enabled by several genome assembly versions generated from either CHO cell lines or Chinese hamster tissue (Brinkrolf et al., 2013; Lewis et al., 2013; Rupp et al., 2018; Xu et al., 2011).”
Self-citationBryan, L. L. K., CLYNES, M. M., & Meleady, P. (2021) · Biotechnology Advances · doi:10.1016/j.biotechadv.2021.107757 · Cited by 50
Hackl, M., Jadhav, V., Jakobi, T., Rupp, O., Brinkrolf, K., Goesmann, A., Pühler, A., Noll, T., Borth, N., & Grillari, J. (2012) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2012.01.019 · Cited by 47
Targeted biopharmaceuticals for cancer treatment
Zhou, L., Xu, N., Sun, Y. P., & Liu, M. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.06.020 · Cited by 48
Systems glycobiology for glycoengineering
Spahn, P. N., & Lewis, N. E. (2014) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2014.08.004 · Cited by 46
Self-citationBennun, S. V., Hızal, D. B., Heffner, K. M., Can, Ö., Zhang, H., & Betenbaugh, M. J. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.07.005 · Cited by 47
Self-citationZhong, X., Ma, W., Meade, C., Tam, A. S. P., Llewellyn, E., Cornell, R. J., Cote, K., Scarcelli, J. J., Marshall, J. K., Tzvetkova, B., et al. (2018) · Biotechnology Progress · doi:10.1002/btpr.2724 · Cited by 47
CRISPR/Cas9‐Mediated Knockout of MicroRNA‐744 Improves Antibody Titer of CHO Production Cell Lines
Raab, N., Mathias, S., Alt, K., Handrick, R., Fischer, S., Schmieder, V., Jadhav, V., Borth, N., & Otte, K. (2019) · Biotechnology Journal · doi:10.1002/biot.201800477 · Cited by 49
Vos, G. M., Hooijschuur, K. C., Li, Z., Fjeldsted, J. C., Klein, C., de Vries, R. P., Toraño, J. S., & Boons, G. (2023) · Nature Communications · doi:10.1038/s41467-023-42575-x · Cited by 48
“Theseobservationsagree with the fact that CHO cells only express α 2,3-linked sialosides 49 .”
Schmieder, V., Bydlinski, N., Strasser, R., Baumann, M., Kildegaard, H. F., Jadhav, V., & Borth, N. (2017) · Biotechnology Journal · doi:10.1002/biot.201700211 · Cited by 46
Laux, H., Romand, S., Nuciforo, S., Farady, C. J., Tapparel, J. A. R., Büchmann-Møller, S., Sommer, B., Oakeley, E. J., & Bodendorf, U. (2018) · Biotechnology and Bioengineering · doi:10.1002/bit.26731 · Cited by 47
Amann, T., Schmieder, V., Faustrup Kildegaard, H., Borth, N., & Andersen, M. R. (2019) · Biotechnology and Bioengineering · doi:10.1002/bit.27101 · Cited by 46
“A major advantage, and this is in particular true for CHO, is the fact that they are more resistant towards adventitious contamination by human viruses, which results in enhanced safety and reduced viral inactivation and clearance efforts during downstream processing (Xu et al., 2011).”
InfluentialSelf-citationHeterologous protein production using euchromatin-containing expression vectors in mammalian cells
Zboray, K., Sommeregger, W., Bogner, E., Gili, A., Sterovsky, T., Fauland, K., Grabner, B., Stiedl, P., Moll, H. P., Bauer, A., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv475 · Cited by 46
Examination of soluble integrin resistant mutants of foot-and-mouth disease virus
Lawrence, P., LaRocco, M., Baxt, B., & Rieder, E. A. (2013) · Virology Journal · doi:10.1186/1743-422x-10-2 · Cited by 45
In silico design of context-responsive mammalian promoters with user-defined functionality
Brown, A. J., Gibson, S. J., Hatton, D., & James, D. C. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx768 · Cited by 47
Comprehensive Glycoproteomic Analysis of Chinese Hamster Ovary Cells
Yang, G., Hu, Y., Sun, S., OuYang, C., Yang, W., Wang, Q., Betenbaugh, M. J., & Zhang, H. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b03520 · Cited by 45
Self-citationBlondeel, E. J. M., & Aucoin, M. G. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.06.008 · Cited by 46
Bydlinski, N., Maresch, D., Schmieder, V., Klanert, G., Strasser, R., & Borth, N. (2018) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2018.07.015 · Cited by 46
Lee, J. S., Park, J. H., Ha, T. K., Samoudi, M., Lewis, N. E., Palsson, B. Ø., Kildegaard, H. F., & Lee, G. M. (2018) · ACS Synthetic Biology · doi:10.1021/acssynbio.8b00290 · Cited by 45
Self-citationBioprocess and Fermentation Monitoring
Pohlscheidt, M., Charaniya, S., Bork, C., Jenzsch, M., Noetzel, T. L., & Luebbert, A. (2013) · Encyclopedia of Industrial Biotechnology · doi:10.1002/9780470054581.eib606.pub2 · Cited by 45
Matuszczyk, J., Teleki, A., Pfizenmaier, J., & Takors, R. (2015) · Biotechnology Journal · doi:10.1002/biot.201500060 · Cited by 44
What can mathematical modelling say about CHO metabolism and protein glycosylation?
Galleguillos, S. N., Ruckerbauer, D. E., Gerstl, M. P., Borth, N., Hanscho, M., & Zanghellini, J. (2017) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2017.01.005 · Cited by 46
“However, after the complete genomic sequence of CHO-K1 was published in 2011 [57], several research groups around the world joined forces in creating the first community-curated GSMR of CHO, which just now became available [58].”
Welch, J., & Arden, N. (2019) · Biologicals · doi:10.1016/j.biologicals.2019.09.006 · Cited by 44
Reunanen, A. (1983) · PubMed · Cited by 44
Screening Strategies for High-Yield Chinese Hamster Ovary Cell Clones
Yang, W., Zhang, J., Xiao, Y., Li, W., & Wang, T. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.858478 · Cited by 47
Galactosyltransferase 4 is a major control point for glycan branching in N-linked glycosylation
McDonald, A. G., Hayes, J. M., Bezak, T., Gluchowska, S. A., Cosgrave, E. F. J., Struwe, W. B., Stroop, C. J. M., Kok, H. J., van de Laar, T., Rudd, P. M., et al. (2014) · Journal of Cell Science · doi:10.1242/jcs.151878 · Cited by 44
Transcriptome‐Based Identification of the Optimal Reference CHO Genes for Normalisation of qPCR Data
Brown, A. J., Gibson, S. J., Hatton, D., & James, D. C. (2017) · Biotechnology Journal · doi:10.1002/biot.201700259 · Cited by 43
Biological strategies for oligo/polysaccharide synthesis: biocatalyst and microbial cell factory
Zhao, L., Ma, Z., Yin, J., Shi, G., & Ding, Z. (2021) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2021.117695 · Cited by 43
Matrix and Backstage: Cellular Substrates for Viral Vaccines
Jordan, I., & Sandig, V. (2014) · Viruses · doi:10.3390/v6041672 · Cited by 44
Onitsuka, M., Kim, W.-D., Ozaki, H., Kawaguchi, A., Honda, K., Kajiura, H., Fujiyama, K., Asano, R., Kumagai, I., Ohtake, H., et al. (2012) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-011-3814-1 · Cited by 48
Chung, C., Yin, B., Wang, Q., Chuang, K.-Y., Chu, J. H., & Betenbaugh, M. J. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.05.023 · Cited by 42
Self-citationGeneration of monoclonal antibody-producing mammalian cell lines
Ho, S. C., Tong, Y. W., & Yang, Y. (2013) · Pharmaceutical Bioprocessing · doi:10.4155/pbp.13.8 · Cited by 41
Efficient Recombinant Production in Mammalian Cells Using a Novel IR/MAR Gene Amplification Method
Araki, Y., Hamafuji, T., Noguchi, C., & Shimizu, N. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041787 · Cited by 41
Metadata
- Authors
- Xu, X., Nagarajan, H., Lewis, N. E., Pan, S., Cai, Z., Liu, X., Chen, W., Xie, M., Wang, W., Hammond, S., Andersen, M. R., Neff, N., Passarelli, B., Koh, W., Fan, H. C., Wang, J., Gui, Y., Lee, K. H., Betenbaugh, M. J., Quake, S. R., Famili, I., Palsson, B. O., & Wang, J.
- Affiliations
- BGI Group (China) (CN)
- Peking University Shenzhen Hospital (CN)
- Delaware Biotechnology Institute (US)
- Technical University of Denmark (DK)
- Howard Hughes Medical Institute (US)
- Johns Hopkins University (US)
- Corresponding author
- Wang, Jianbin
- Wang, Jun
- ORCID
- Venue
- Nature Biotechnology
- Published
- 2011-08
- Volume
- 29
- Issue
- 8
- Pages
- 735-741
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- PMC
- PMC3164356
- OpenAlex
- W2093343938
- Cited by
- 785
- References
- 53
- Citations by year
- 2026: 22 · 2025: 25 · 2024: 37 · 2023: 35 · 2022: 39 · 2021: 58 · 2020: 38 · 2019: 45 · 2018: 78 · 2017: 57 · 2016: 59 · 2015: 77 · 2014: 79 · 2013: 64 · 2012: 53
- FWCI
- 27.29
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Nature Biotechnology (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Technical University of Denmark, DTU Orbit (Technical University of Denmark, DTU) (submittedVersion)
- Funders
- Novo Nordisk Fonden (NNF10CC1016517)
- National Cancer Institute (R44CA139977)
- National Center for Research Resources (P20RR016472)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Viral Infectious Diseases and Gene Expression in Insects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- Keywords
- CHO-K1 cells, CHO cells, draft genome sequence, therapeutic protein production, monoclonal antibodies, virus resistance, cell line engineering, genome assembly, gene expression
- MeSH terms
- Animals, Chromosome Mapping, Cricetulus, Glycosylation, Cricetinae, Models, Biological, Molecular Sequence Data, CHO Cells, Genome, Sequence Analysis, DNA, Genomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
